Rivus Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
Rivus Pharmaceuticals has raised $132M across 1 funding round on record, the most recent a Series B of $132M announced in Sep 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rivus Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Rivus Pharmaceuticals Funding Rounds
Rivus Pharmaceuticals Founders and Leadership Team
Contact details for the Rivus Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Rivus Pharmaceuticals Funding Compared to Other Biotechnology Startups
Rivus Pharmaceuticals' latest round of $132M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rivus Pharmaceuticals in Biotechnology and Charlottesville
Companies Similar to Rivus Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Rivus Pharmaceuticals Funding FAQs
What does Rivus Pharmaceuticals do?
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
How much funding has Rivus Pharmaceuticals raised?
Rivus Pharmaceuticals has raised $132M across 1 round on record. The most recent is a Series B of $132M announced in Sep 2022.
When did Rivus Pharmaceuticals last raise funding?
Rivus Pharmaceuticals' most recent funding round on record is a Series B of $132M, announced in Sep 2022.
Who is the CEO of Rivus Pharmaceuticals?
Allen Cunningham is listed as CEO at Rivus Pharmaceuticals.
Where is Rivus Pharmaceuticals headquartered?
Rivus Pharmaceuticals is based in Charlottesville, Virginia, United States.
How many employees does Rivus Pharmaceuticals have?
Rivus Pharmaceuticals is in the 11-50 employee band.
How does Rivus Pharmaceuticals' funding compare to other Biotechnology startups?
Rivus Pharmaceuticals' latest round of $132M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Rivus Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rivus Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.